Retatrutide, a GIP, GLP-1, and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial
We also know that even though the WHI focused on long-term HRT use for chronic disease prevention in women over age 60, the results were generalized to younger women who were using short-term HRT to manage midlife symptoms like hot flashes, not to prevent disease
CHA is highly toxic, even at minimal doses
IV glutathione can produce visible results the same day
The bacterial translocation and Paneth cell defect alter host-bacterial interactions within the intestine, further enhancing morbidity in Glp2r / mice (Lee et al., 2012)
The higher absorption of the injectable route can mean lower total dosing, but the supplies, prescription, and monitoring add cost